Literature DB >> 16574732

Clinimetric properties of a walking scale in peripheral neuropathy.

R C Graham1, R A C Hughes.   

Abstract

Difficulty in walking is seen in many people with peripheral neuropathies, but walking ability is not comprehensively measured by commonly used outcome measures. The clinimetric properties of the 12-Item Multiple Sclerosis Walking Scale (MSWS-12, renamed the Walk-12) were investigated in 65 patients with peripheral neuropathies. Owing to its excellent internal consistency and reliability, and strong correlation with measures of physical and social function (r>0.8), the Walk-12 is recommended for measuring walking ability in peripheral neuropathies.

Entities:  

Mesh:

Year:  2006        PMID: 16574732      PMCID: PMC2077614          DOI: 10.1136/jnnp.2005.081497

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12).

Authors:  C McGuigan; M Hutchinson
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

2.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome.

Authors:  R P Kleyweg; F G van der Meché; P I Schmitz
Journal:  Muscle Nerve       Date:  1991-11       Impact factor: 3.217

3.  Residual health status after Guillain-Barré syndrome.

Authors:  R A Bernsen; H M Jacobs; A E de Jager; F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

4.  Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

5.  Quality of life complements traditional outcome measures in immune-mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

6.  Individual-patient monitoring in clinical practice: are available health status surveys adequate?

Authors:  C A McHorney; A R Tarlov
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

7.  Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).

Authors:  J C Hobart; A Riazi; D L Lamping; R Fitzpatrick; A J Thompson
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

  7 in total
  9 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

2.  Polyneuropathy dysfunction scores.

Authors:  P J Dyck; P C O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-18       Impact factor: 10.154

3.  The Influence of Walking Limitations on Daily Life: A Mixed-Methods Study of 14 Persons with Late Effects of Polio.

Authors:  Christina Brogårdh; Jan Lexell; Catharina Sjödahl Hammarlund
Journal:  Int J Environ Res Public Health       Date:  2022-07-03       Impact factor: 4.614

4.  A study of physical activity comparing people with Charcot-Marie-Tooth disease to normal control subjects.

Authors:  Gita M Ramdharry; Alexander J Pollard; Robert Grant; Elizabeth L Dewar; Matilde Laurá; Sarah A Moore; Kate Hallsworth; Thomas Ploetz; Michael I Trenell; Mary M Reilly
Journal:  Disabil Rehabil       Date:  2016-08-16       Impact factor: 3.033

5.  Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.

Authors:  Emanuela Pagliano; Isabella Moroni; Giovanni Baranello; Anita Magro; Alessia Marchi; Sara Bulgheroni; Maurizio Ferrarin; Davide Pareyson
Journal:  J Peripher Nerv Syst       Date:  2011-09       Impact factor: 3.494

6.  Reliability of instrumented movement analysis as outcome measure in Charcot-Marie-Tooth disease: results from a multitask locomotor protocol.

Authors:  M Ferrarin; G Bovi; M Rabuffetti; P Mazzoleni; A Montesano; I Moroni; E Pagliano; A Marchi; C Marchesi; E Beghi; D Pareyson
Journal:  Gait Posture       Date:  2011-04-21       Impact factor: 2.840

7.  Physical activity of children and adolescents with Charcot-Marie-Tooth neuropathies: A cross-sectional case-controlled study.

Authors:  Rachel A Kennedy; Kate Carroll; Kade L Paterson; Monique M Ryan; Joshua Burns; Kristy Rose; Jennifer L McGinley
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

Review 8.  Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.

Authors:  Rachel A Kennedy; Kate Carroll; Jennifer L McGinley; Kade L Paterson
Journal:  J Foot Ankle Res       Date:  2020-03-02       Impact factor: 2.303

9.  Postural stabilization and balance assessment in Charcot-Marie-Tooth 1A subjects.

Authors:  T Lencioni; M Rabuffetti; G Piscosquito; D Pareyson; A Aiello; E Di Sipio; L Padua; F Stra; M Ferrarin
Journal:  Gait Posture       Date:  2014-07-15       Impact factor: 2.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.